Changes in the prevalence of synthetic cannabinoids and cathinone derivatives in Japan until early 2012

Overview of attention for article published in Forensic Toxicology, November 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

policy: 2 policy sources

Citations

dimensions_citation: 88 Dimensions

Readers on

mendeley: 34 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 3 policy documents that reference this research output.

Report on the risk assessment of methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA) in the framework of the Council Decision on new psychoactive substances

Cited by European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) on 16 Jul 2018

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the leading authority on illicit drugs in the European Union.

Report on the risk assessment of N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA) in the framework of the Council Decision on new psychoactive substances

Cited by European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) on 16 Jul 2018

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the leading authority on illicit drugs in the European Union.

Wettelijke mogelijkheden om het gebruik van designer drugs tegen te gaan

Cited by Rijksinstituut voor Volksgezondheid en Milieu on 29 Apr 2014

RIVM works to prevent and control outbreaks of infectious diseases. We promote public health and consumer safety, and we help to protect the quality of the environment.